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Recurrent variceal bleeding in liver transplant candidates with end-stage liver disease can complicate or even prohibit a subsequent transplant procedure (OLT) . Endoscopic sclero-therapy and medical therapy are considered as first-line management with surgical shunts reserved for refractory situations. Surgical shunts can be associated with a high mortality in this population and may complicate subsequent OLT. The transjugular intrahepatic portosystemic shunt (TIPS) has been recommended in these patients as a bridge to OLT. This is a new modality that has not been compared with previously established therapies such as the distal splenorenal shunt (DSRS) . In this study we report our [6] . Prevention of variceal bleeding is important because mortality dramatically increases after bleeding occurs. Non-selective beta blockers may be used to prevent the first variceal hemorrhage in patients with end stage liver disease; patients with decompensated liver disease and medium to large varices are most likely to benefit [7, 8] . Prevention of initial variceal hemorrhage through shunt surgery is not beneficial. Prophylatic sclerotherapy of varices is also not an effective preventive strategy [8, 9] . Patients [16-181. TIPS controls acute variceal bleeding and prevents rebleeding in patients refractory to standard medical and endoscopic therapy. [19] [20] [21] [22] TIPS has been associated with a variety of complications [20] [21] [22] . Fifteen 
